机译:微卫星不稳定性,ERCC1 / XRCC1多态性与临床特征的相关性,与结肠直肠癌患者的Folfox佐剂化疗效应
Department of Anus-Intestines Surgery Shaoxing Second Hospital;
Biotecan Medical Diagnostics Co. Ltd Zhangjiang Center for Translational Medicine;
Department of Anus-Intestines Surgery Shaoxing Second Hospital;
Department of Anus-Intestines Surgery Shaoxing Second Hospital;
Department of Anus-Intestines Surgery Shaoxing Second Hospital;
Department of Anus-Intestines Surgery Shaoxing Second Hospital;
Biotecan Medical Diagnostics Co. Ltd Zhangjiang Center for Translational Medicine;
Biotecan Medical Diagnostics Co. Ltd Zhangjiang Center for Translational Medicine;
Microsatellite instability (MSI); ERCC1; XRCC1; colorectal cancer; mFOLFOX6;
机译:微卫星不稳定性,ERCC1 / XRCC1多态性与临床特征的相关性,与结肠直肠癌患者的Folfox佐剂化疗效应
机译:ERCC1和XRCC1基因多态性的组合可以更好地预测基于奥沙利铂的化疗在转移性结直肠癌中的临床结果。
机译:ERCC1和XRCC1基因多态性的结合可以更好地预测以奥沙利铂为基础的化学疗法治疗转移性结直肠癌的临床结局
机译:不应常规向患有阶段结肠癌的患者常规的辅助化学疗法,表明微卫星不稳定性
机译:具有微卫星不稳定性的大肠癌患者的突变谱; BRCA2和EGFR体细胞突变的频率高
机译:ERCC1XRCC1和GSTP1单核苷酸多态性与结肠癌接受奥沙利铂辅助化疗的患者的生存率
机译:ERCC1,XRCC1和GSTP1单核苷酸多态性与以奥沙利铂为基础的辅助化疗的结肠癌患者的生存率